OptimizeRx Corp (OPRX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-10

OptimizeRx Corp (OPRX) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-10. 3 Form 8-K material event filings were reported by OPRX in the last 90 days. InsiderAlpha tracks every OPRX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About OptimizeRx Corp (OPRX)

SIC classification	Services-Business Services, NEC (SIC 7389)
SEC CIK	0001448431

90-Day SEC Filing Activity

Form 4 filings (90d)	8
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-06-10

Recent OPRX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-09	Lang James Paul	Director	A — Grant or award	34.5K	$0.00	—	SEC
2026-06-09	Spangler Patrick D	Director	A — Grant or award	34.5K	$0.00	—	SEC
2026-06-09	WASSON GREGORY D	Director	A — Grant or award	34.5K	$0.00	—	SEC
2026-06-09	KLEMA CATHY	Director	A — Grant or award	34.5K	$0.00	—	SEC
2026-06-09	Vos Ellen O'Connor	Director	A — Grant or award	34.5K	$0.00	—	SEC
2026-05-15	Greco Theresa	Chief Commercial Officer	F — Tax withholding / forfeiture	879	$5.21	$5K	SEC
2026-05-15	Silvestro Stephen L	Chief Executive Officer	F — Tax withholding / forfeiture	5.2K	$5.21	$27K	SEC
2026-05-15	Greco Theresa	Chief Commercial Officer	F — Tax withholding / forfeiture	914	$5.21	$5K	SEC
2026-05-01	Presti Mariyamma Varghese	Director	A — Grant or award	13.1K	$0.00	—	SEC
2026-02-11	Odence-Ford Marion	Chief Legal & Admin Officer	F — Tax withholding / forfeiture	1.4K	$9.23	$13K	SEC
2026-02-11	Odence-Ford Marion	Chief Legal & Admin Officer	M — Option exercise	4.0K	—	—	SEC
2025-10-03	Silvestro Stephen L	Chief Executive Officer	S — Open-market sale	1.6K	$18.75	$30K	SEC
2025-10-03	Odence-Ford Marion	Chief Legal Admin Officer	F — Tax withholding / forfeiture	2.0K	$18.75	$37K	SEC
2025-10-03	Silvestro Stephen L	Chief Executive Officer	M — Option exercise	6.6K	$0.00	—	SEC
2025-10-03	Odence-Ford Marion	Chief Legal Admin Officer	M — Option exercise	6.6K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for OptimizeRx Corp (OPRX). Updated in real time as new filings are submitted to the SEC.

Most-Active OPRX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Greco Theresa	2	$9K
Silvestro Stephen L	1	$27K
WASSON GREGORY D	1	—
Spangler Patrick D	1	—
KLEMA CATHY	1	—

Recent OPRX Form 8-K Material Events

2026-06-12 — Item 5.02, 5.07, 9.01 [SEC]
2026-06-05 — Item 5.02 [SEC]
2026-05-12 — Item 1.01, 1.02, 2.02, 2.03, 9.01 [SEC]
2026-04-08 — Item 5.02, 7.01, 9.01 · Leadership · neutral [SEC]
OptimizeRx Corporation appointed Mary Varghese Presti as an independent director on April 3, 2026, expanding the Board from six to seven members. Ms. Presti was also appointed to the Audit Committee as part of the Company's ongoing board refresh and expansion initiative.
2026-03-30 — Item 4.01, 9.01 · Other · negative [SEC]
OptimizeRx Corporation dismissed UHY LLP as its independent registered public accounting firm effective March 25, 2026. The dismissal was not due to disagreements on accounting principles or audit scope, but the company has a previously disclosed material weakness in internal con

Recent Insider Filings

2026-06-10 — KLEMA CATHY (Director)
2026-06-10 — Lang James Paul (Director)
2026-06-10 — Spangler Patrick D (Director)
2026-06-10 — Vos Ellen O'Connor (Director)
2026-06-10 — WASSON GREGORY D (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in OPRX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

OPRX Insider Trading — FAQ

What is the latest insider trade for OPRX?: OptimizeRx Corp (OPRX) had 8 insider filings in the last 90 days, with the most recent on 2026-06-10. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying OPRX stock?: 0 insider purchases of OPRX were filed in the last 90 days.
How many insiders are selling OPRX stock?: 0 insider sales of OPRX were filed in the last 90 days.
Where can I see OPRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every OPRX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live OPRX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.